Autoantibodies to genomic dsDNA (anti-dsDNA) and to β-2-glycoprotein I (anti-β2GPI, IgG, and IgM) were evaluated during the clinical work-up of a patient with an increased likelihood of SLE. Here, CD40LG is linked to systemic lupus erythematosus.